Surgical Site Infection Control Market Report 2024

The surgical site infection control market size has grown strongly in recent years. It will grow from $4.51 billion in 2023 to $4.74 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth observed in the historic period can be attributed to several factors, including increasing awareness and emphasis on infection prevention protocols, integration of infection control outcomes into healthcare practices, rising concerns regarding antibiotic resistance, the transition towards value-based care models, and rigorous implementation of regulatory standards and guidelines.

The surgical site infection control market size is expected to see strong growth in the next few years. It will grow to $5.81 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing demand for minimally invasive surgical procedures, a growing aging population leading to higher surgical volumes, rising preference for single-use infection control products, investments in healthcare infrastructure development, and initiatives focused on enhancing patient safety. Key trends expected in this period include ongoing advancements in sterilization methods and technologies, innovations in surgical techniques, a rise in outpatient surgeries, increased adoption of single-use and disposable products for infection control, and the development of advanced personal protective equipment (PPE) solutions.

The surgical site infection control market is poised for growth driven by an increasing number of surgical procedures. This rise is attributed to technological advancements, a growing elderly population, and escalating burdens of chronic diseases. Surgical site infection control measures, which include sterilization, antibiotic prophylaxis, and strict aseptic techniques, play a crucial role in preventing infections, reducing complications, and enhancing patient outcomes. For example, the Government of British Columbia reported a notable increase in the number of surgeries completed, both scheduled and unscheduled, underscoring the growing demand for these procedures.

Leading companies in the surgical site infection control market are focusing on developing advanced products to stay competitive. One area of innovation is in surgical gowns featuring innovative fabrics, designed to offer enhanced protection and comfort. These gowns utilize advanced materials with improved barrier properties, breathability, and durability. For instance, Invenio Medical Inc. launched the V90 series in March 2022, tailored to meet the rigorous demands of modern healthcare settings while maintaining cost-effectiveness. This series incorporates advanced features aimed at maximizing performance and comfort, reflecting Invenio's commitment to meeting evolving healthcare needs with state-of-the-art technology and practical pricing strategies.

In February 2023, Ansell Limited, an Australian manufacturer, acquired a 50% shareholding in Careplus (M) Sdn Bhd for US$9 million to strengthen its supply chain and production capabilities. Careplus (M) Sdn Bhd, based in Malaysia, specializes in manufacturing surgical, latex, and nitrile powder-free gloves, aligning with Ansell's strategic objectives in the healthcare sector.

Major companies operating in the surgical site infection control market are Johnson and Johnson, Thermo Fisher Scientific Inc., 3M Company, Kimberly-Clark Corporation, Becton Dickinson and Company, Stryker Corporation, Owens & Minor Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc, Terumo Corporation, Smith & Nephew plc, Hartmann Group, ConvaTec Inc., Ansell Limited, Mölnlycke Health Care, Halyard Health Inc., DeRoyal Industries Inc., Excelsior Medical LLC, Xttrium Laboratories Inc., Precept Medical Products Inc., Cantel Medical Corp.

North America was the largest region in the surgical site infection control market in 2023. The regions covered in the surgical site infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the surgical site infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Surgical site infection (SSI) control encompasses a set of practices aimed at preventing infections occurring at or near a surgical incision within 30 days (or up to 90 days for certain surgeries). These practices include maintaining sterile conditions, adhering to proper hand hygiene, administering antibiotic prophylaxis, and ensuring appropriate post-operative wound care. Effective SSI control is crucial for reducing patient morbidity, mortality rates, and healthcare expenditures.

Key product types for surgical site infection control include surgical scrubs, hair clippers, surgical drapes, surgical irrigation systems, skin preparation solutions, medical nonwovens, surgical gloves, manual reprocessor solutions, disinfectants, and other related items. Surgical scrubs are specialized garments worn by surgical personnel to maintain cleanliness and minimize the transmission of microorganisms during procedures. SSIs can manifest as superficial incisional, deep incisional, or organ/space infections, and prevention measures are applied across a range of surgeries such as cesarean sections, gastric bypass, cataract surgery, dental procedures, and more. These products are utilized by hospitals, ambulatory surgical centers, and other healthcare facilities.

The surgical site infection control market research report is one of a series of new reports that provides surgical site infection control market statistics, including surgical site infection control industry global market size, regional shares, competitors with a surgical site infection control market share, detailed surgical site infection control market segments, market trends and opportunities, and any further data you may need to thrive in the surgical site infection control industry. This surgical site infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The surgical site infection control market consists of sales of sterile surgical gloves and instruments, antiseptic skin preparation solutions, and post-operative dressings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.